nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Dementia—Thalidomide—leprosy	0.0388	0.039	CcSEcCtD
Carbidopa—White blood cell count decreased—Thalidomide—leprosy	0.032	0.0322	CcSEcCtD
Carbidopa—Venous thrombosis—Thalidomide—leprosy	0.0295	0.0297	CcSEcCtD
Carbidopa—Serum creatinine increased—Thalidomide—leprosy	0.0259	0.026	CcSEcCtD
Carbidopa—Lung disorder—Thalidomide—leprosy	0.0225	0.0226	CcSEcCtD
Carbidopa—Psychotic disorder—Dapsone—leprosy	0.022	0.0222	CcSEcCtD
Carbidopa—Nasopharyngitis—Dapsone—leprosy	0.0202	0.0203	CcSEcCtD
Carbidopa—Numbness—Thalidomide—leprosy	0.0192	0.0193	CcSEcCtD
Carbidopa—Sensory loss—Thalidomide—leprosy	0.0184	0.0185	CcSEcCtD
Carbidopa—Neuropathy peripheral—Dapsone—leprosy	0.017	0.0171	CcSEcCtD
Carbidopa—Dyskinesia—Thalidomide—leprosy	0.0169	0.017	CcSEcCtD
Carbidopa—Gait disturbance—Thalidomide—leprosy	0.0163	0.0164	CcSEcCtD
Carbidopa—Blood urea increased—Thalidomide—leprosy	0.015	0.0151	CcSEcCtD
Carbidopa—Hyperkinesia—Thalidomide—leprosy	0.0139	0.014	CcSEcCtD
Carbidopa—Euphoric mood—Thalidomide—leprosy	0.0137	0.0138	CcSEcCtD
Carbidopa—Vascular purpura—Thalidomide—leprosy	0.0129	0.013	CcSEcCtD
Carbidopa—Vision blurred—Dapsone—leprosy	0.0128	0.0129	CcSEcCtD
Carbidopa—Dermatitis bullous—Thalidomide—leprosy	0.0121	0.0122	CcSEcCtD
Carbidopa—Purpura—Thalidomide—leprosy	0.012	0.0121	CcSEcCtD
Carbidopa—Cough—Dapsone—leprosy	0.0119	0.0119	CcSEcCtD
Carbidopa—Hyponatraemia—Thalidomide—leprosy	0.0116	0.0117	CcSEcCtD
Carbidopa—Pain in extremity—Thalidomide—leprosy	0.0115	0.0116	CcSEcCtD
Carbidopa—Diplopia—Thalidomide—leprosy	0.0115	0.0116	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.0115	0.0116	CcSEcCtD
Carbidopa—Disturbance in sexual arousal—Thalidomide—leprosy	0.0115	0.0115	CcSEcCtD
Carbidopa—Psychotic disorder—Thalidomide—leprosy	0.0113	0.0113	CcSEcCtD
Carbidopa—Ataxia—Thalidomide—leprosy	0.0109	0.0109	CcSEcCtD
Carbidopa—Blood creatinine increased—Thalidomide—leprosy	0.0108	0.0109	CcSEcCtD
Carbidopa—Orthostatic hypotension—Thalidomide—leprosy	0.0105	0.0106	CcSEcCtD
Carbidopa—Cramp muscle—Thalidomide—leprosy	0.0104	0.0105	CcSEcCtD
Carbidopa—Insomnia—Dapsone—leprosy	0.01	0.0101	CcSEcCtD
Carbidopa—Dysphagia—Thalidomide—leprosy	0.00998	0.01	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Thalidomide—leprosy	0.00927	0.00933	CcSEcCtD
Carbidopa—Pollakiuria—Thalidomide—leprosy	0.00922	0.00928	CcSEcCtD
Carbidopa—Weight increased—Thalidomide—leprosy	0.00908	0.00914	CcSEcCtD
Carbidopa—Gastrointestinal pain—Dapsone—leprosy	0.00906	0.00912	CcSEcCtD
Carbidopa—Weight decreased—Thalidomide—leprosy	0.00903	0.00909	CcSEcCtD
Carbidopa—Depression—Thalidomide—leprosy	0.00887	0.00893	CcSEcCtD
Carbidopa—Acute coronary syndrome—Thalidomide—leprosy	0.00877	0.00883	CcSEcCtD
Carbidopa—Body temperature increased—Dapsone—leprosy	0.00876	0.00882	CcSEcCtD
Carbidopa—Abdominal pain—Dapsone—leprosy	0.00876	0.00882	CcSEcCtD
Carbidopa—Myocardial infarction—Thalidomide—leprosy	0.00872	0.00878	CcSEcCtD
Carbidopa—Neuropathy peripheral—Thalidomide—leprosy	0.00872	0.00878	CcSEcCtD
Carbidopa—Agranulocytosis—Thalidomide—leprosy	0.0083	0.00836	CcSEcCtD
Carbidopa—Rhinitis—Thalidomide—leprosy	0.00801	0.00806	CcSEcCtD
Carbidopa—Hypoaesthesia—Thalidomide—leprosy	0.00795	0.008	CcSEcCtD
Carbidopa—Urinary tract disorder—Thalidomide—leprosy	0.00789	0.00794	CcSEcCtD
Carbidopa—Urethral disorder—Thalidomide—leprosy	0.00783	0.00788	CcSEcCtD
Carbidopa—Alopecia—Thalidomide—leprosy	0.00706	0.0071	CcSEcCtD
Carbidopa—Vomiting—Dapsone—leprosy	0.00705	0.00709	CcSEcCtD
Carbidopa—Mental disorder—Thalidomide—leprosy	0.007	0.00704	CcSEcCtD
Carbidopa—Headache—Dapsone—leprosy	0.00694	0.00699	CcSEcCtD
Carbidopa—Flatulence—Thalidomide—leprosy	0.00685	0.0069	CcSEcCtD
Carbidopa—Tension—Thalidomide—leprosy	0.00682	0.00687	CcSEcCtD
Carbidopa—Dysgeusia—Thalidomide—leprosy	0.00681	0.00685	CcSEcCtD
Carbidopa—Nervousness—Thalidomide—leprosy	0.00675	0.0068	CcSEcCtD
Carbidopa—Back pain—Thalidomide—leprosy	0.00672	0.00677	CcSEcCtD
Carbidopa—Muscle spasms—Thalidomide—leprosy	0.00668	0.00673	CcSEcCtD
Carbidopa—Epinephrine—TNF—leprosy	0.00662	1	CrCbGaD
Carbidopa—Nausea—Dapsone—leprosy	0.00658	0.00663	CcSEcCtD
Carbidopa—Vision blurred—Thalidomide—leprosy	0.00655	0.0066	CcSEcCtD
Carbidopa—Tremor—Thalidomide—leprosy	0.00651	0.00656	CcSEcCtD
Carbidopa—Ill-defined disorder—Thalidomide—leprosy	0.00645	0.00649	CcSEcCtD
Carbidopa—Anaemia—Thalidomide—leprosy	0.00643	0.00647	CcSEcCtD
Carbidopa—Agitation—Thalidomide—leprosy	0.00639	0.00643	CcSEcCtD
Carbidopa—Angioedema—Thalidomide—leprosy	0.00635	0.00639	CcSEcCtD
Carbidopa—Malaise—Thalidomide—leprosy	0.00627	0.00631	CcSEcCtD
Carbidopa—Syncope—Thalidomide—leprosy	0.00623	0.00628	CcSEcCtD
Carbidopa—Leukopenia—Thalidomide—leprosy	0.00622	0.00626	CcSEcCtD
Carbidopa—Palpitations—Thalidomide—leprosy	0.00614	0.00618	CcSEcCtD
Carbidopa—Loss of consciousness—Thalidomide—leprosy	0.00611	0.00615	CcSEcCtD
Carbidopa—Cough—Thalidomide—leprosy	0.00607	0.00611	CcSEcCtD
Carbidopa—Convulsion—Thalidomide—leprosy	0.00602	0.00606	CcSEcCtD
Carbidopa—Hypertension—Thalidomide—leprosy	0.006	0.00604	CcSEcCtD
Carbidopa—Chest pain—Thalidomide—leprosy	0.00592	0.00596	CcSEcCtD
Carbidopa—Anxiety—Thalidomide—leprosy	0.0059	0.00594	CcSEcCtD
Carbidopa—Discomfort—Thalidomide—leprosy	0.00585	0.00589	CcSEcCtD
Carbidopa—Dry mouth—Thalidomide—leprosy	0.00579	0.00583	CcSEcCtD
Carbidopa—Confusional state—Thalidomide—leprosy	0.00572	0.00576	CcSEcCtD
Carbidopa—Oedema—Thalidomide—leprosy	0.00567	0.00571	CcSEcCtD
Carbidopa—Infection—Thalidomide—leprosy	0.00564	0.00567	CcSEcCtD
Carbidopa—Shock—Thalidomide—leprosy	0.00558	0.00562	CcSEcCtD
Carbidopa—Thrombocytopenia—Thalidomide—leprosy	0.00556	0.00559	CcSEcCtD
Carbidopa—Hyperhidrosis—Thalidomide—leprosy	0.00548	0.00552	CcSEcCtD
Carbidopa—Anorexia—Thalidomide—leprosy	0.00541	0.00544	CcSEcCtD
Carbidopa—Hypotension—Thalidomide—leprosy	0.0053	0.00534	CcSEcCtD
Carbidopa—Insomnia—Thalidomide—leprosy	0.00513	0.00517	CcSEcCtD
Carbidopa—Paraesthesia—Thalidomide—leprosy	0.00509	0.00513	CcSEcCtD
Carbidopa—Dyspnoea—Thalidomide—leprosy	0.00506	0.00509	CcSEcCtD
Carbidopa—Somnolence—Thalidomide—leprosy	0.00504	0.00508	CcSEcCtD
Carbidopa—Dyspepsia—Thalidomide—leprosy	0.00499	0.00503	CcSEcCtD
Carbidopa—Decreased appetite—Thalidomide—leprosy	0.00493	0.00496	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Thalidomide—leprosy	0.0049	0.00493	CcSEcCtD
Carbidopa—Fatigue—Thalidomide—leprosy	0.00489	0.00492	CcSEcCtD
Carbidopa—Pain—Thalidomide—leprosy	0.00485	0.00488	CcSEcCtD
Carbidopa—Constipation—Thalidomide—leprosy	0.00485	0.00488	CcSEcCtD
Carbidopa—Feeling abnormal—Thalidomide—leprosy	0.00468	0.00471	CcSEcCtD
Carbidopa—Gastrointestinal pain—Thalidomide—leprosy	0.00464	0.00467	CcSEcCtD
Carbidopa—Urticaria—Thalidomide—leprosy	0.00451	0.00454	CcSEcCtD
Carbidopa—Body temperature increased—Thalidomide—leprosy	0.00449	0.00451	CcSEcCtD
Carbidopa—Abdominal pain—Thalidomide—leprosy	0.00449	0.00451	CcSEcCtD
Carbidopa—Hypersensitivity—Thalidomide—leprosy	0.00418	0.00421	CcSEcCtD
Carbidopa—Asthenia—Thalidomide—leprosy	0.00407	0.0041	CcSEcCtD
Carbidopa—Pruritus—Thalidomide—leprosy	0.00401	0.00404	CcSEcCtD
Carbidopa—Diarrhoea—Thalidomide—leprosy	0.00388	0.00391	CcSEcCtD
Carbidopa—Dizziness—Thalidomide—leprosy	0.00375	0.00378	CcSEcCtD
Carbidopa—Vomiting—Thalidomide—leprosy	0.00361	0.00363	CcSEcCtD
Carbidopa—Rash—Thalidomide—leprosy	0.00358	0.0036	CcSEcCtD
Carbidopa—Dermatitis—Thalidomide—leprosy	0.00357	0.0036	CcSEcCtD
Carbidopa—Headache—Thalidomide—leprosy	0.00355	0.00358	CcSEcCtD
Carbidopa—Nausea—Thalidomide—leprosy	0.00337	0.00339	CcSEcCtD
